FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040382169> ?p ?o ?g. }

• W2040382169 endingPage "598" @default.
• W2040382169 startingPage "592" @default.
• W2040382169 abstract "BackgroundPerimembranous ventricular septal defects (pmVSDs) are one of the most common forms of congenital cardiac malformation in children. Results of transcatheter pmVSD closure remain debatable, prompting the need for further evaluation with regard to the safety and efficacy of this procedure. The aim of the study was to analyze the safety, efficacy, and long-term follow-up data associated with transcatheter closure of pmVSDs in children using symmetric occluders.MethodsFrom December 2002 to October 2011, 525 children with pmVSDs between 2 and 12 years of age underwent transcatheter closure at three major heart centers in northwest China with symmetric pmVSD occluders. All patients were followed up until October 2011 with electrocardiogram and transthoracic echocardiography. Adverse events were recorded and evaluated.ResultsThere were 252 male and 273 female patients with an average weight of 21.5 kg. The mean age at the time of transcatheter closure was 5.6 years, and the average ratio of pulmonic to systemic blood flow was 2.5. Transcatheter intervention was successfully performed in 502 patients (95.6%). The median device size implanted was 6.5 mm (range, 4 to 18 mm). During a median 45-month follow-up period, no mortality occurred. A total of three major adverse events (0.6%) were reported; two were valve-related. Meanwhile, 104 minor adverse events were detected during the entire follow-up period. All individuals experiencing major adverse events were younger than 3 years of age. The incidence of major adverse events in patients younger than 3 years old was significantly higher than that of patients older than 3 years old (3.75% versus 0.00%; Fisher's exact test p = 0.004).ConclusionsData from the current study suggest that transcatheter pmVSD closure using symmetric occluders displayed an excellent success rate and long-term follow-up results. The transcatheter approach provides a less-invasive alternative to open surgery and displays some promise in the treatment of pmVSDs in certain patient populations. Perimembranous ventricular septal defects (pmVSDs) are one of the most common forms of congenital cardiac malformation in children. Results of transcatheter pmVSD closure remain debatable, prompting the need for further evaluation with regard to the safety and efficacy of this procedure. The aim of the study was to analyze the safety, efficacy, and long-term follow-up data associated with transcatheter closure of pmVSDs in children using symmetric occluders. From December 2002 to October 2011, 525 children with pmVSDs between 2 and 12 years of age underwent transcatheter closure at three major heart centers in northwest China with symmetric pmVSD occluders. All patients were followed up until October 2011 with electrocardiogram and transthoracic echocardiography. Adverse events were recorded and evaluated. There were 252 male and 273 female patients with an average weight of 21.5 kg. The mean age at the time of transcatheter closure was 5.6 years, and the average ratio of pulmonic to systemic blood flow was 2.5. Transcatheter intervention was successfully performed in 502 patients (95.6%). The median device size implanted was 6.5 mm (range, 4 to 18 mm). During a median 45-month follow-up period, no mortality occurred. A total of three major adverse events (0.6%) were reported; two were valve-related. Meanwhile, 104 minor adverse events were detected during the entire follow-up period. All individuals experiencing major adverse events were younger than 3 years of age. The incidence of major adverse events in patients younger than 3 years old was significantly higher than that of patients older than 3 years old (3.75% versus 0.00%; Fisher's exact test p = 0.004). Data from the current study suggest that transcatheter pmVSD closure using symmetric occluders displayed an excellent success rate and long-term follow-up results. The transcatheter approach provides a less-invasive alternative to open surgery and displays some promise in the treatment of pmVSDs in certain patient populations." @default.
• W2040382169 created "2016-06-24" @default.
• W2040382169 creator A5004145725 @default.
• W2040382169 creator A5004655678 @default.
• W2040382169 creator A5007706452 @default.
• W2040382169 creator A5013675782 @default.
• W2040382169 creator A5018465799 @default.
• W2040382169 creator A5022285422 @default.
• W2040382169 creator A5024139316 @default.
• W2040382169 creator A5033180082 @default.
• W2040382169 creator A5036656675 @default.
• W2040382169 creator A5051626151 @default.
• W2040382169 creator A5062922367 @default.
• W2040382169 creator A5073216396 @default.
• W2040382169 creator A5086214229 @default.
• W2040382169 creator A5089496808 @default.
• W2040382169 creator A5029854657 @default.
• W2040382169 date "2012-08-01" @default.
• W2040382169 modified "2023-10-18" @default.
• W2040382169 title "Transcatheter Closure of Congenital Perimembranous Ventricular Septal Defect in Children Using Symmetric Occluders: An 8-Year Multiinstitutional Experience" @default.
• W2040382169 cites W151529953 @default.
• W2040382169 cites W1741216385 @default.
• W2040382169 cites W1975278732 @default.
• W2040382169 cites W1979393228 @default.
• W2040382169 cites W1981367402 @default.
• W2040382169 cites W2012517517 @default.
• W2040382169 cites W2019549924 @default.
• W2040382169 cites W2022669168 @default.
• W2040382169 cites W2053560661 @default.
• W2040382169 cites W2063733348 @default.
• W2040382169 cites W2078997658 @default.
• W2040382169 cites W2086040841 @default.
• W2040382169 cites W2088483141 @default.
• W2040382169 cites W2095792262 @default.
• W2040382169 cites W2106705551 @default.
• W2040382169 cites W2120386885 @default.
• W2040382169 cites W2132577887 @default.
• W2040382169 cites W2165858244 @default.
• W2040382169 cites W79239381 @default.
• W2040382169 doi "https://doi.org/10.1016/j.athoracsur.2012.03.067" @default.
• W2040382169 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22626754" @default.
• W2040382169 hasPublicationYear "2012" @default.
• W2040382169 type Work @default.
• W2040382169 sameAs 2040382169 @default.
• W2040382169 citedByCount "30" @default.
• W2040382169 countsByYear W20403821692013 @default.
• W2040382169 countsByYear W20403821692014 @default.
• W2040382169 countsByYear W20403821692015 @default.
• W2040382169 countsByYear W20403821692016 @default.
• W2040382169 countsByYear W20403821692017 @default.
• W2040382169 countsByYear W20403821692018 @default.
• W2040382169 countsByYear W20403821692019 @default.
• W2040382169 countsByYear W20403821692020 @default.
• W2040382169 countsByYear W20403821692021 @default.
• W2040382169 countsByYear W20403821692022 @default.
• W2040382169 countsByYear W20403821692023 @default.
• W2040382169 crossrefType "journal-article" @default.
• W2040382169 hasAuthorship W2040382169A5004145725 @default.
• W2040382169 hasAuthorship W2040382169A5004655678 @default.
• W2040382169 hasAuthorship W2040382169A5007706452 @default.
• W2040382169 hasAuthorship W2040382169A5013675782 @default.
• W2040382169 hasAuthorship W2040382169A5018465799 @default.
• W2040382169 hasAuthorship W2040382169A5022285422 @default.
• W2040382169 hasAuthorship W2040382169A5024139316 @default.
• W2040382169 hasAuthorship W2040382169A5029854657 @default.
• W2040382169 hasAuthorship W2040382169A5033180082 @default.
• W2040382169 hasAuthorship W2040382169A5036656675 @default.
• W2040382169 hasAuthorship W2040382169A5051626151 @default.
• W2040382169 hasAuthorship W2040382169A5062922367 @default.
• W2040382169 hasAuthorship W2040382169A5073216396 @default.
• W2040382169 hasAuthorship W2040382169A5086214229 @default.
• W2040382169 hasAuthorship W2040382169A5089496808 @default.
• W2040382169 hasBestOaLocation W20403821691 @default.
• W2040382169 hasConcept C120665830 @default.
• W2040382169 hasConcept C121332964 @default.
• W2040382169 hasConcept C126322002 @default.
• W2040382169 hasConcept C141071460 @default.
• W2040382169 hasConcept C164705383 @default.
• W2040382169 hasConcept C197934379 @default.
• W2040382169 hasConcept C2777010224 @default.
• W2040382169 hasConcept C2777385415 @default.
• W2040382169 hasConcept C61511704 @default.
• W2040382169 hasConcept C71924100 @default.
• W2040382169 hasConceptScore W2040382169C120665830 @default.
• W2040382169 hasConceptScore W2040382169C121332964 @default.
• W2040382169 hasConceptScore W2040382169C126322002 @default.
• W2040382169 hasConceptScore W2040382169C141071460 @default.
• W2040382169 hasConceptScore W2040382169C164705383 @default.
• W2040382169 hasConceptScore W2040382169C197934379 @default.
• W2040382169 hasConceptScore W2040382169C2777010224 @default.
• W2040382169 hasConceptScore W2040382169C2777385415 @default.
• W2040382169 hasConceptScore W2040382169C61511704 @default.
• W2040382169 hasConceptScore W2040382169C71924100 @default.
• W2040382169 hasIssue "2" @default.
• W2040382169 hasLocation W20403821691 @default.
• W2040382169 hasLocation W20403821692 @default.
• W2040382169 hasOpenAccess W2040382169 @default.
• W2040382169 hasPrimaryLocation W20403821691 @default.

• next